Source: International Congress 2017 – Infant lung disease: physiology, assessment and novel therapies 
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Poggi (Florence, Italy). Recombinant human (rh)IGF-1/rhIGFBP-3 for prevention of bronchopulmonary dysplasia.. 3423

Member's Comments

No comment yet.

Related content which might interest you: Aerosolized IL-1β receptor antgonist: potential prevention of bronchopulmonary dysplasia? Source: Eur Respir J 2006; 28: Suppl. 50, 361s Year: 2006 Prediction of bronchopulmonary dysplasia Source: Annual Congress 2009 - Neonatal respiratory disorders Year: 2009 P16 in bronchopulmonary dysplasia: Early determinant of respiratory disease? Source: International Congress 2017 – Postnatal lung growth and development Year: 2017 Pathogenesis of bronchopulmonary dysplasia Source: Eur Respir Monogr 2021; 92: 50-67 Year: 2021 Bronchopulmonary dysplasia and chronic lung disease of prematurity Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine Year: 2017 Bronchopulmonary dysplasia and chronic lung disease of prematurity Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019 Year: 2019 Bronchopulmonary dysplasia and chronic lung disease of prematurity Source: ERS Course 2018 - Summer school of paediatric respiratory medicine Year: 2018 Bronchopulmonary dysplasia and chronic lung disease of prematurity Source: ERS Skills Course 2016 Year: 2016 Neonatal resuscitation and respiratory support in prevention of bronchopulmonary dysplasia Source: Breathe 2011; 8: 14-23 Year: 2011 Research lung function for children with bronchopulmonary dysplasia in the past Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Antenatal infection in the rabbit impairs post-natal growth and lung alveolarisation Source: Eur Respir J 2008; 32: 1520-1528 Year: 2008 Lung function abnormalities in infants developing bronchopulmonary dysplasia Source: Annual Congress 2010 - Paediatric and neonatal intensive care Year: 2010 Evolution of lung function in preterm infants with or without bronchopulmonary dysplasia Source: Annual Congress 2011 - New insights in paediatric respiratory physiology Year: 2011 Long-term sequelae of bronchopulmonary dysplasia Source: Eur Respir Monogr 2021; 92: 68-78 Year: 2021 Imbalanced type I TGF-β receptor signalling in the pulmonary vasculature: implications for the pathogenesis of bronchopulmonary dysplasia Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 Long term management of bronchopulmonary dysplasia Source: ERS Webinar 2020: Long term management of bronchopulmonary dysplasia Year: 2020 Bullous emphysema in adolescent: is congenital malformation or outcome of bronchopulmonary dysplasia? Source: International Congress 2019 – Paediatric respiratory diseases Year: 2019 Bronchopulmonary dysplasia as a cause of pulmonary hypertension Source: Virtual Congress 2020 – Don't blame your parents: causes of pulmonary hypertension in early life Year: 2020 Functional capacity in pre-term bronchopulmonary dysplasia Source: Annual Congress 2010 - Dysfunctional breathing, asthma and respiratory physiotherapy problems Year: 2010